What are the treatment options for androgenetic alopecia (hair loss)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Androgenetic Alopecia (Hair Loss)

First-Line Treatment

Topical minoxidil 5% applied twice daily is the primary first-line treatment for androgenetic alopecia, which must be continued indefinitely as discontinuation reverses all hair growth benefits. 1, 2, 3

  • Apply 1 mL twice daily directly to the scalp in areas of hair loss using the dropper applicator 4
  • Results typically appear at 2 months with twice-daily use, though some patients may require 4 months of treatment before seeing improvement 4
  • The medication works by reactivating hair follicles to stimulate regrowth 4
  • Initial shedding may occur for up to 2 weeks when starting treatment, which is expected as old hairs are replaced by new growth 4

Enhanced Combination Therapy (Superior to Monotherapy)

For patients seeking optimal results, combining topical minoxidil 5% with platelet-rich plasma (PRP) therapy demonstrates significantly superior efficacy compared to minoxidil alone. 1, 2, 3

PRP Treatment Protocol:

  • Initial phase: 3-5 treatment sessions spaced 1 month apart 1, 2
  • Maintenance phase: 1 session every 6 months after completing initial treatment 1, 2
  • Dosing: 5-7 mL of PRP per session, injected at 0.05-0.1 mL/cm² 1
  • Technique: Use 30G × 4mm needles at 90-degree angle, 2-4mm depth, with injections spaced 1 cm apart 1
  • Preparation: Manual double-spin method with platelet concentration of 1-1.5 million platelets per µL; activation is NOT required 1
  • Pain management: Apply pharmaceutical-grade topical anesthetic cream before injection due to significant discomfort 1

Expected Outcomes with Combination Therapy:

  • Hair density increases by 27.7-45.9 hairs/cm² compared to baseline 2
  • Combined therapy increases hair density 1.74 times and hair diameter 14.3 times 2
  • 83% of patients achieve negative hair pull test (indicating reduced hair fragility) after PRP combined with minoxidil 1

Alternative Advanced Option

The combination of topical minoxidil 5% with topical finasteride 0.25% represents the most effective medical treatment approach, demonstrating significantly superior efficacy compared to either monotherapy. 2

  • This option avoids systemic finasteride exposure while maintaining efficacy 5
  • Topical finasteride causes less marked decrease in serum dihydrotestosterone levels than oral intake 5

Monitoring Treatment Response

Evaluate treatment efficacy using multiple objective methods at regular intervals to ensure adequate response. 1, 2, 3

Assessment Tools:

  • Standardized before-and-after photographs 1, 2, 3
  • Trichoscopy to evaluate hair density and diameter 1, 3
  • Hair pull tests to evaluate hair fragility 1
  • Patient self-assessment questionnaires 1, 3

Key Response Indicators:

  • Increased hair density and shaft diameter 2
  • Decreased proportion of telogen (resting phase) hairs 2
  • Improved patient satisfaction scores 2
  • Negative hair pull test after treatment 1

Important Application Guidelines for Minoxidil

  • Allow minoxidil to remain on scalp for approximately 4 hours before washing 4
  • If using hair styling products, apply minoxidil first and allow it to soak into the scalp before applying styling aids 4
  • Use mild shampoo if washing scalp before application 4
  • Hair coloring, perming, or relaxers are permitted, but ensure all minoxidil is washed off before chemical treatments and wait 24 hours after chemical treatments before resuming minoxidil 4

Critical Warnings and Contraindications

Do not use minoxidil 5% if: 4

  • You are a woman (women should use 2% minoxidil formulation instead) 3, 4
  • Hair loss is on the front of scalp or receding hairline (minoxidil 5% is intended for vertex/crown hair loss only) 4
  • Scalp is red, inflamed, infected, irritated, or painful 4
  • Under 18 years of age 4

Stop use immediately and consult a physician if: 4

  • Chest pain, rapid heartbeat, faintness, or dizziness occurs 4
  • Sudden unexplained weight gain or swelling of hands/feet develops 4
  • Scalp irritation or redness persists 4
  • Unwanted facial hair growth occurs 4
  • No hair regrowth is seen after 4 months 4

Common Side Effects

  • Most common: itching and skin irritation of treated scalp area 4
  • Alcohol content may cause burning if accidentally applied to eyes (rinse with cool tap water if this occurs) 4
  • Rare: unwanted hair growth on face or body (reversible upon discontinuation) 4
  • With oral minoxidil: dose-dependent hypertrichosis (unwanted body hair growth) 3

Emerging Alternative: Platelet-Rich Fibrin (PRF)

PRF represents a promising alternative to PRP with theoretical advantages including longer growth factor release, though high-quality comparative studies are currently lacking. 2

  • PRF functions as both scaffold and reservoir for growth factors with prolonged release 2
  • May be more cost-effective than PRP 2
  • Shows particular efficacy in mild androgenetic alopecia cases 2
  • No randomized controlled trials comparing PRF to PRP are currently available 6

Additional Treatment Options (Lower Evidence Quality)

Low-level laser light therapy (LLLT) is FDA-cleared for androgenetic alopecia and demonstrates efficacy in clinical trials. 7, 8

  • Recommended usage: three times per week 1
  • Devices use wavelengths between 630-660 nm 5
  • Can be used at home for 15-30 minutes daily 5
  • Meta-analysis confirms superiority to placebo (P < .00001) 7

Common Pitfalls to Avoid

  • Inadequate follow-up: Failure to assess treatment response regularly leads to suboptimal outcomes 1
  • Premature discontinuation: Stopping treatment before 4 months prevents adequate assessment of efficacy 4
  • Inconsistent application: Missing doses or applying less than twice daily reduces effectiveness 4
  • Unrealistic expectations: Treatment efficacy decreases with severity and duration of alopecia 1
  • Wrong formulation for gender: Women using 5% minoxidil instead of 2% formulation may experience unwanted facial hair growth 3, 4

References

Guideline

Treatment Options for Female Androgenetic Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Androgenetic Alopecia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Androgenetic Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

What's New in Therapy for Male Androgenetic Alopecia?

American journal of clinical dermatology, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Physical Treatments and Therapies for Androgenetic Alopecia.

Journal of clinical medicine, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.